Skip to main content
MESA LABORATORIES INC /CO/ logo

MESA LABORATORIES INC /CO/ — Investor Relations & Filings

Ticker · MLAB ISIN · US59064R1095 LEI · 549300ZCG738WLX8ZW79 US Manufacturing
Open in API
Filings indexed 1,017 across all filing types
Latest filing 2010-05-21 Director's Dealing
Country US United States of America
Listing US MLAB

About MESA LABORATORIES INC /CO/

https://mesalabs.com

Mesa Laboratories, Inc. designs, manufactures, and markets quality control products and services for regulated industries. The company specializes in life sciences tools and critical quality control solutions, including analytical instruments and related consumables. Its products are utilized primarily in the pharmaceutical, healthcare, and medical device sectors to ensure product safety, integrity, and performance. Mesa Laboratories focuses on applying technical expertise and technological innovation to help customers monitor and maintain high standards, supporting compliance with various regulatory requirements and international standards for quality management, testing, and calibration.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2010-05-21 English
PRIMARY DOCUMENT
Director's Dealing
2010-05-21 English
PRIMARY DOCUMENT
Director's Dealing
2010-05-21 English
PRIMARY DOCUMENT
Director's Dealing
2010-05-21 English
PRIMARY DOCUMENT
Director's Dealing
2010-05-21 English
Regulatory Filings 2010
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the United States Securities and Exchange Commission referencing a previously filed Form 10-K for the fiscal year ended March 31, 2009. The letter provides detailed responses to SEC comments regarding segment reporting and financial disclosures in the 10-K filing. It discusses product lines, segment aggregation criteria, and financial data such as revenues, cost of goods sold, and gross margins by product line. The letter also mentions plans to comply with disclosure requests in future filings and the expected date for filing amended Form 10-Qs. The content is a correspondence responding to regulatory review comments rather than the actual 10-K report itself. It does not contain the full annual report or comprehensive financial statements but addresses specific audit and disclosure issues. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory correspondence responding to SEC comments on a previously filed 10-K, not the 10-K report itself.
2010-05-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.